Abstract-The effects of various agents on the activity of brain thiamine triphos phatase (TTPase) in vivo and in vitro were studied. Thiamine deficiency caused a significant increase in soluble TTPase activity and a decrease in membrane-associated TTPase activity. Insulin and a fasting state did not affect these enzyme activities. DL-Methamphetamine (10 mg/kg i.p.) increased the activity of the soluble TTPase, whereas reserpine (2.5 mg/kg i.p.) caused no change in the enzyme activities. A single injection of chlopromazine (25 mg/kg s.c.) had no effect on the microsomal or soluble TTPase activities, but repeated injections reduced the activity of the micro somal enzyme. The effects of various neuroactive agents on microsomal TTPase activity were examined in vitro. Among the drugs tested, only chlorpromazine caused marked inhibition of the enzyme activity.
The specific participation of phosphorylated thiamine in nerve conduction has been suggested by many workers (1) (2) (3) (4) , but the nature of this participation has not been elu cidated at the molecular level. Several enzymic analyses of thiamine diphosphate in brain have been reported (5) (6) (7) . Recently the possible significance of thiamine triphos phate (TTP) in nervous function was demonstrated (8) , and very recently, the existence and some properties of TTPase in rat brain were reported (9, 10) .
Previously we also studied the properties of the soluble and membrane-associated TTPases and our results indicated that Ca" may regulate their activities (11) . However, there are no drugs known to affect these enzyme activities and the role of the enzymes in nerve function has not been clarified. In this work, we examined the effects of thiamine deficiency, insulin, fasting states and various neuroactive agents on TTPase activity in vivo and in vitro.
MATERIALS AND METHODS
TTP was a gift from Sankyo Co., Ltd., Tokyo. Purity was determined by paper elec trophoresis (11) to be 97% TTP. No further dephosphorylation of the product of the enzymic reaction was detectable as described previously (11) .
Soluble and microsomal fractions were prepared from the brains of male adult rats as described previously (11) . In some experiments (Tables 1 and 2 ), brain tissue was homogenized in 50 mM tris buffer (pH 7.8) instead of 0.25 M sucrose. In this case ma terial precipitated by centrifugation at 1000-g for 10 min (membrane-associated frac tion) and the supernatant obtained by centrifugation at 105000 x g for 60 min (soluble fraction) were used as enzyme sources. Hydrolysis of TTP was measured by determin ing the release of inorganic phosphate by the method of Baginski et al. (12) . The standard reaction mixture contained: for soluble TTPase, 100 mM tris buffer (pH 9.0), 6 mM MgC12, 3 mM substrate and about 300 jug/ml of protein; for membrane-associated TTP ase, 100 mM tris-maleate buffer (pH 6.5), 3 mM MgC12, 3 mM substrate and about 600 ttg/ml of protein in a final volume of 0.5 ml. After 5 min of pre-incubation, incubation was started by addition of TTP and carried out for 30 min at 37°C and the reaction was terminated by addition of cold trichloroacetic acid to a final concentration of 5 %. Thi amine-deficient and pair-fed rats were obtained by the method of Iwata et al. (13) . When the animals on the thiamine-deficient diet showed a heart rate of less than 70'/'0' of that of the control group they were regarded as acutely deficient, and used in the experiments. The total thiamine content in the brains of these animals, estimated by the method of Fujiwara and Matsui (14), was less than 30% that of normal rats. These animals ex hibited various symptoms such as body weight-loss, tremor, ataxia, frequent seizure, opisthotonus and circular walk.
RESULTS

Effects of thiamine deficiency (in vivo)
As shown in Table 1 , in thiamine-deficient rats the activity of soluble TTPase in the brain was significantly more than that of pair-fed animals, and the activity of membrane associated TTPase significantly was less than that of normal animals. There was no sig nificant difference in the enzyme activities in the livers of these three groups.
Effects of insulin and fasting (in vivo)
Injection of insulin (5 i.u./kg i.p.) or fasting for 48 hr did not influence TTPase ac tivity ( Table 2 ). Effects of neuroactive agents (in vivo) Table 3 shows the effects of DL-methamphetamine, reserpine and chlorpromazine on the soluble and microsomal TTPase activities in the brain. One hr after the injection of DL-methamphetamine (10 mg/kg i.p.), the soluble TTPase activity was increased. Re serpine (2.5 mg/kg i.p.) did not cause any change in either TTPase activity (Exp. A). A single injection of chlorpromazine (25 mg/kg s.c.) had no effect on the microsomal TTPase activity, but repeated injections reduced the activity significantly. The soluble TTPase activity was not influenced by either single or repeated injections of the drug (Exp. B).
Effects of various neuroactive agents (in vitro)
As shown in Table 4 , acetylcholine, noradrenaline, tyramine and diphenylhydantoin had no effects on the microsomal TTPase activity, but 1.0 mM colchicine caused a slight decrease in enzyme activity. Concentrations of 0.25 to 1.0 mM chlorpromazine strongly inhibited the enzyme activity causing 17 to 61 % inhibition. Hashitani and Cooper demonstrated a soluble TTPase in rat brain and its regula tion by Ca" (9), while Barchi and Braun reported the existence of membrane-associated enzyme in rat brain and its inhibition by ADP (10) . We also studied the properties of these two enzymes and results indicated possible regulation of activity by physiological concentrations of Ca (11) .
In the present work we found that some drugs affected TTPase activity in vitro or in 1110. DL-Methamphetamine increased the activity of the soluble enzyme, whereas re peated injections of a sedative dose of chlorpromazine inhibited the microsomal enzyme activity. However, reserpine did not affect the enzyme activity. Therefore, at present the relationship between the changes of the enzyme activities and functional changes of the animals induced by these drugs is not clear.
We reported previously that thiamine diphosphatase activity in rat brain was signifi cantly elevated in thiamine deficiency (15) . The present results show that thiamine de ficiency causes an increase in soluble TTPase activity and a decrease in membrane-as sociated enzyme activity in the brain. Taking into account the possible significance of TTP in the central nervous system (8) and of the appearance of neural symptoms in thi amine deficiency, this finding is of interest.
Next, we examined the effect of calorigenic factor on TTPase activity using insulin or food-deprivation, but no change in the enzyme activity was observed.
Neuroactive agents, such as acetylcholine and tetrodotoxin, cause release of dephos phorylated thiamine from membrane fragments of nervous tissue (3). Hashitani and Cooper reported that these agents have no effect on the soluble TTPase activity in vitro (9) . In this work, we examined the effects of some neuroactive agents on the activity of microsomal TTPase in vitro. Most of the drugs tested had no affect, but at concentrations of 0.25 to 1.0 mM chlorpromazine caused 17 to 61 % inhibition.
It has been suggested that chlorpromazine inhibits ATPase in brain microsomes and may induce a change in membrane permeability (16) (17) (18) . Since dephosphorylation of phosphorylated thiamines is associated with ion movement across the nerve membrane (3), our data showing that chlorpromazine inhibits TTPase also suggest the possible participa tion of this enzyme in nervous function. But it is still uncertain whether the concentra tions of chloropromazine tested correspond at all to those which might be expected in vivo. Detailed analysis of the action of chlorpromazine on thiamine metabolism is now in progress.
As there have been no previous reports on the effects of drugs on TTPase activity in vivo or in vitro, our findings that thiamine deficiency, DL-methamphetamine and chlor promazine can alter the enzyme activity should be applicable in further investigation of the role of thiamine metabolism in the central nervous system.
